Market revenue in 2023 | USD 698.3 million |
Market revenue in 2030 | USD 1,236.8 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.72% in 2023. Horizon Databook has segmented the Asia Pacific implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific region is experiencing significant growth in the implantable cardioverter defibrillators (ICD) market. Growth in the region can be attributed to the high prevalence of Cardiovascular Diseases (CVD) in countries like China, India, and Japan.
For instance, in April 2022, according to a research article titled Cardiovascular Disease Mortality and Potential Risk Factors in China: A Multi-Dimensional Assessment by a Grey Relational Approach, approximately 290 million people in China suffer from various cardiac disorders, including stroke, coronary heart disease, heart failure, and hypertension.
This substantial burden of CVD and the related mortalities contribute to the increasing demand for cardiology medical devices, such as ICDs, for diagnosis and treatment. In addition to the growing healthcare burden, companies in China, India, and Japan are actively developing advanced technologies to address the needs of the population affected by CVD.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific implantable cardioverter defibrillators market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account